In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Ivax buys generics company Zenith Laboratories

Executive Summary

Medical and chemical holding company Ivax is buying Zenith Laboratories (generics) for about $600 million in Ivax stock (1.307 Ivax common shares for each Zenith share). The acquisition creates the world's largest generics company. 12/94: finalized.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register